Post by
Noteable on Mar 09, 2023 12:32pm
Shortage of generic cancer drugs should trigger FDA AA actio
Shortage of generic cancer drugs should trigger FDA and EU action to increase the level of Accelerated Approvals (AA) of new cancer biologics to begin addressing the generic cancer drug shortages that have been experienced in NA and Europe for the past several years and which are expected to continue into the foreseeable future.
The issues with generic cancer drug production stem from the fact that most are commonly manufactured in India and the FDA has continued to issue countless manufacturing violation letters to those Indian manufacturers producing drugs that are intended for use in North America and Europe.
https://endpts.com/short-supply-of-commonly-used-cancer-drugs-raises-concerns-among-hospital-pharmacists/
https://www.euractiv.com/section/health-consumers/news/berlin-aims-to-fend-off-drugs-shortages-without-general-prices-adjustments/
Comment by
Noteable on Mar 09, 2023 3:07pm
February 27, 2023 - Doctors are being forced to make life-or-death decisions because of a nationwide medication shortage. https://www.wsbradio.com/news/local/doctors-forced-make-life-death-decisions-over-nationwide-drug-shortage/LHIYETFZT5CEHOQBGP6ZX6KHOU/